|
|
Type of Company:
Type:
|
Company
|
Ownership: |
Publicly Traded |
Company Size: |
10-19 Employees In BC (10-19 Total)
10-19 In BC (10-19 Total)
|
Year Founded: |
2017 |
Sector: |
Biotech/Life Sciences
Biotech/Life Sciences
|
Region: |
Lower Mainland / South Coast
Lower Mainland
|
Tags: |
NervGen Pharma Corp.
|
|
|
|
NervGen is a publicly traded (TSX-V: NGEN, OTCQX: NGENF) clinical stage biotech company dedicated to discovering and developing treatments for patients suffering from medical conditions related to nerve damage, either as a result of injury, neurodegenerative disease, or other causes. |
|
|
Date |
Type |
Amount |
Investors |
Jul 18, 2022 |
Private Placement |
$15 Million USD |
|
Jun 30, 2022 |
Private Placement |
$15 Million USD |
|
Nov 14, 2021 |
Private Placement |
$9.2 Million CAD |
|
Date |
Type |
Amount |
Investors |
Jul 18, 2022 |
Private Placement |
$15M USD |
|
Jun 30, 2022 |
Private Placement |
$15M USD |
|
Nov 14, 2021 |
Private Placement |
$9.2M CAD |
|
|
|
|
Want More NervGen Pharma Corp. News? 1 2
|
Next »
|
|
|
|
|
|
|
|
11 - 18 of 18 results
|
|
 |
|
|
|
Share This Company Profile |
|
|
|
Disclaimer: Company Profiles in the Tech Directory on T-Net are created, edited and maintained primarily by employees within individual companies, and are subject to continual change without notice and possible errors and/or omissions. Information within the pages of this Tech Directory is of a general nature intended only for informational purposes, and such information should not be relied upon. T-Net does not warrant or guarantee the quality, accuracy or completeness of such information and expressly disclaims liability for any loss, inconvenience or damages (including special, indirect or consequential damages) caused as a result of any errors in, or omissions from, such information. If you see an error, please let us know. Copyright T-Net. All rights reserved.
|
|
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
